<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have shown that modulation of intracellular calcium in EBV latently infected cells could induce the expression of <z:mp ids='MP_0001799'>viral</z:mp> antigens, and suggested that a protein kinase-C (PKC) may play a major role in the EBV genome activation </plain></SENT>
<SENT sid="1" pm="."><plain>We now report further investigations on the role of PKC using 2 selective enzymatic inhibitors [<z:chebi fb="0" ids="43385">1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine</z:chebi>] (H-7) and <z:chebi fb="0" ids="15738">Staurosporine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>We show that these inhibitors can abrogate the inductive effect of <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> or the combination of <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> plus <z:chebi fb="0" ids="17968">n-butyrate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The inhibitors have no effect on induction by <z:chebi fb="0" ids="22986">calcium ionophores</z:chebi> or by <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In this context the effect of <z:chebi fb="1" ids="9948">verapamil</z:chebi> (a specific <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi>) and of several calmodulin <z:chebi fb="68" ids="48706">antagonists</z:chebi> was investigated </plain></SENT>
<SENT sid="5" pm="."><plain>No inhibitory effect of these agents could be demonstrated on any of the induction systems examined </plain></SENT>
<SENT sid="6" pm="."><plain>These observations strengthen the idea that in some instances cellular PKC plays a role in the expression of <z:mp ids='MP_0001799'>viral</z:mp> antigens; however, alternative regulatory mechanisms cannot be excluded </plain></SENT>
</text></document>